NGM Biopharmaceuticals, Inc. (NGM) has a market capitalization of $128.53M and trades at $1.54. The 52-week range is 0.6002-4.69.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.9, Earnings Per Share (EPS) of $-1.73, annual revenue of $4.42M.
The stock has a beta of 1.26, operates in the Healthcare sector.
